Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Neovasc Inc (NVCN.TO)

Neovasc Inc (NVCN.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Neovasc Inc 13562 Maycrest Way Suite 5138 Richmond BC V6V 2J7 CAN

https://www.neovasc.com P: 604-270-4344 F: 604-270-4384

Description:

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.

Key Statistics

Overview:

Market Capitalization, $K 111,760
Shares Outstanding, K 2,759
Annual Sales, $ 2,547 K
Annual Net Income, $ -24,889 K
Last Quarter Sales, $ 923 K
Last Quarter Net Income, $ -8,227 K
60-Month Beta 1.82
% of Institutional Shareholders 0.40%

Growth:

1-Year Return 208.85%
3-Year Return -30.17%
5-Year Return -97.71%
5-Year Revenue Growth -23.17%

Per-Share Information:

Latest Earnings Date 05/11/23
Earnings Per Share ttm -15.07
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 04/29/22

NVCN.TO Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -78.25%
Return-on-Assets % -57.42%
Profit Margin % -977.04%
Debt/Equity 0.16
Price/Sales 21.51
Price/Book 5.22
Book Value/Share 7.69
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar